The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Beta-Crosslaps, C-Telopeptide, C-Telopeptide, Serum, Collagen Type I CTelopeptide CTx, CTX, CTX, Beta-Crosslaps
The Collagen Type I C-Telopeptide (CTx) test contains 1 test with 1 biomarker.
Brief Description: The Collagen Type I C-Telopeptide test, often abbreviated as CTX test, is a blood or urine test used to evaluate the rate of bone resorption, which is the process of bone breakdown. Type I collagen is the most prevalent form of collagen found in bone. When bone is broken down, fragments of collagen, including C-telopeptide fragments, are released into the bloodstream and excreted in the urine.
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: Fasting is required. Fasting morning collection 8-10am. (diurnal variations cause elevated levels at night)
A Collagen Type I C-Telopeptide test may be ordered:
Bone Health Monitoring: To assess the rate of bone turnover in patients, especially postmenopausal women or older adults who may be at risk for osteoporosis.
Therapy Evaluation: To monitor the efficacy of osteoporosis treatments. A decrease in CTX levels after initiating therapy could indicate a reduction in bone loss.
Risk Assessment: For patients on medications that might affect bone health, such as corticosteroids.
The test measures the concentration of C-telopeptide fragments in blood or urine. Elevated levels suggest increased bone resorption, which can be indicative of bone disorders like osteoporosis or other metabolic bone diseases.
When a CTx test is ordered, it's often part of a broader evaluation of bone health. Here are some tests commonly ordered alongside it:
Serum Calcium and Phosphorus:
Parathyroid Hormone (PTH) Test:
Vitamin D Test (25-Hydroxyvitamin D):
Estrogen and Testosterone tests:
These tests, when ordered alongside a Collagen Type I C-Telopeptide test, provide a comprehensive evaluation of bone health and metabolism. They are crucial for diagnosing conditions like osteoporosis, assessing fracture risk, and guiding treatment decisions. The specific combination of tests will depend on the individual’s age, sex, risk factors for bone disease, and any underlying health conditions.
The primary conditions or diseases include:
Osteoporosis: A condition characterized by weak and brittle bones, making them more susceptible to fractures.
Paget’s Disease: A condition where bone is broken down and rebuilt at an accelerated rate.
Bone Metastases: Some cancers can spread to the bone, increasing resorption.
The results of the Collagen Type I C-Telopeptide test offer healthcare providers:
Diagnosis Support: Elevated CTX levels might support a diagnosis of osteoporosis or another metabolic bone disease.
Treatment Evaluation: The test can be used to gauge the efficacy of treatments intended to slow bone resorption.
Risk Stratification: High CTX levels might prompt more aggressive treatment strategies in patients at risk for fractures.
In conclusion, the Collagen Type I C-Telopeptide test is an important tool for evaluating bone health, guiding treatment decisions, and monitoring the efficacy of therapies designed to address metabolic bone disorders.
Why is the Collagen Type I C-Telopeptide test ordered?
The Collagen Type I C-Telopeptide test is primarily ordered to assess bone resorption rates. The test measures the concentration of C-terminal telopeptide of type I collagen, a marker that is released into the blood when bone is broken down. It's often used to assess osteoporosis risk, monitor osteoporosis treatment, or diagnose diseases associated with increased bone turnover.
Can the Collagen Type I C-Telopeptide test diagnose osteoporosis on its own?
No, the Collagen Type I C-Telopeptide test is just one of many tools used to diagnose and monitor osteoporosis. While it can provide insights into bone resorption rates, it doesn't give a comprehensive overview of bone density. For that, other tests, such as bone densitometry (DXA), are also required.
What does a high Collagen Type I C-Telopeptide test result mean?
A high result indicates increased bone turnover, which might suggest a higher risk of osteoporosis or fractures. It can also be indicative of certain conditions like hyperparathyroidism, Paget's disease, or metastatic bone disease.
Is a low result on the Collagen Type I C-Telopeptide test good?
Generally, a low result means there's less bone turnover, which might be seen as favorable when monitoring the efficacy of osteoporosis treatment. However, extremely low values might also raise concerns about overly suppressed bone turnover, which could lead to atypical fractures or other complications.
How can the results of the Collagen Type I C-Telopeptide test influence treatment decisions?
If the test shows elevated bone resorption despite treatment for osteoporosis, a healthcare provider might consider adjusting the treatment plan. The test can be used to monitor the effectiveness of therapy and might also guide the decision to start, continue, or stop specific treatments.
How frequently should the Collagen Type I C-Telopeptide test be done?
The frequency varies based on the individual's health status and the purpose of testing. If it's used for monitoring osteoporosis treatment, it might be ordered at regular intervals to track changes. It's essential to follow the healthcare provider's recommendation regarding test frequency.
How does the Collagen Type I C-Telopeptide test differ from other bone turnover tests?
The Collagen Type I C-Telopeptide test specifically measures the C-terminal telopeptide of type I collagen. Other bone turnover tests might assess different markers or aspects of bone metabolism. For instance, tests like the bone-specific alkaline phosphatase or osteocalcin provide information on bone formation, whereas the Collagen Type I C-Telopeptide test focuses on bone resorption.
Is the Collagen Type I C-Telopeptide test preferred over other bone resorption markers?
The preference depends on the clinical scenario and the healthcare provider's judgment. The Collagen Type I C-Telopeptide test is widely recognized for its sensitivity and specificity to bone resorption. However, other markers might be chosen based on availability, cost, or specific clinical considerations.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.